Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer’s disease therapy - Top-Institutions - MDSpire

Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer’s disease therapy

  • By

  • Xizhong Ding

  • Xukai Hu

  • Wanqiang Xue

  • Yingrui An

  • Wei Cheng

  • Shaolong Zhang

  • Anhua Lei

  • Jin Zhang

  • July 14, 2026

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

  • #2

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, Illinois

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

  • #3

    Massachusetts Alzheimer’s Disease Research Center
    Massachusetts Alzheimer’s Disease Research Center

    Boston, Massachusetts

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

  • #4

    University of Washington
    University of Washington

    Seattle, Washington

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

  • #5

    Weizmann Institute of Science
    Weizmann Institute of Science

    Rehovot, Israel

    Key Differentiators

    • Neurology
    • Alzheimer's Disease Research

Original Source(s)

Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer’s disease therapy

  • by Xizhong Ding, Xukai Hu, Wanqiang Xue, Yingrui An, Wei Cheng, Shaolong Zhang, Anhua Lei, Jin Zhang

  • July 14, 2026

Related Content

MIAT: An important long non-coding RNA regulating cardiovascular and cerebrovascular diseases

FDA Approves At-Home Starting Dose for Lecanemab

Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.

Global research landscape and emerging trends of tertiary lymphoid structures in autoimmune diseases: a bibliometric analysis